erythrosine and 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1h-imidazol-2-yl)benzamide

erythrosine has been researched along with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1h-imidazol-2-yl)benzamide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baumann, J; Gassmann, M; Huang, SF; Ogunshola, OO; Tsao, CC	1

Other Studies

1 other study(ies) available for erythrosine and 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1h-imidazol-2-yl)benzamide

Article	Year
Furin inhibition prevents hypoxic and TGFβ-mediated blood-brain barrier disruption. Experimental cell research, 2019, 10-15, Volume: 383, Issue:2 Topics: Amino Acid Chloromethyl Ketones; Animals; Benzamides; Blood-Brain Barrier; Capillary Permeability; Cell Membrane Permeability; Cell Movement; Cells, Cultured; Dioxoles; Endothelial Cells; Enzyme Inhibitors; Fluoresceins; Furin; Hypoxia; Male; Rats; Rats, Wistar; Receptor, Transforming Growth Factor-beta Type I; Signal Transduction; Transforming Growth Factor beta	2019

Article

Year

Furin inhibition prevents hypoxic and TGFβ-mediated blood-brain barrier disruption.

Experimental cell research, 2019, 10-15, Volume: 383, Issue:2

Topics: Amino Acid Chloromethyl Ketones; Animals; Benzamides; Blood-Brain Barrier; Capillary Permeability; Cell Membrane Permeability; Cell Movement; Cells, Cultured; Dioxoles; Endothelial Cells; Enzyme Inhibitors; Fluoresceins; Furin; Hypoxia; Male; Rats; Rats, Wistar; Receptor, Transforming Growth Factor-beta Type I; Signal Transduction; Transforming Growth Factor beta

2019